Disparities in Influenza, Pneumococcal, COVID-19 Vaccine Coverage in High-Risk Adults Aged 19 to 64 Years in Southeastern Minnesota, 2010-2021

被引:3
|
作者
Felzer, Jamie R. [1 ]
Montgomery, Amy J. [2 ]
Lemahieu, Allison M. [3 ]
Rutten, Lila J. Finney [4 ]
Juhn, Young J. [5 ,6 ]
Wi, Chung-Il [5 ,6 ]
Jacobson, Robert M. [4 ,5 ,6 ,7 ]
Kennedy, Cassie C. [1 ,8 ,9 ]
机构
[1] Mayo Clin, Div Pulm & Crit Care, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Med, Rochester, MN USA
[3] Mayo Clin, Div Clin Trials & Biostat, Rochester, MN USA
[4] Mayo Clin, Div Epidemiol, Rochester, MN USA
[5] Mayo Clin, Dept Quantitat Hlth Sci, Div Community Pediat Med, Rochester, MN USA
[6] Mayo Clin, Dept Quantitat Hlth Sci, Div Adolescent Med, Rochester, MN USA
[7] Mayo Clin, Div Pediat Infect Dis, Rochester, MN USA
[8] Mayo Clin, Dept Pediat & Adolescent Med, Div Hlth Care Delivery Res, Rochester, MN 55905 USA
[9] Mayo Clin, Resp Hlth Equ Clin Res Lab, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
adult; health care disparities; respiratory tract infections; risk factors; sociodemographic factors; vaccines; MEDICAL-RECORDS-LINKAGE; DATA RESOURCE PROFILE; ADVISORY-COMMITTEE; CONJUGATE VACCINE; UNITED-STATES; SOCIOECONOMIC-STATUS; UPDATED RECOMMENDATIONS; POLYSACCHARIDE VACCINE; DISEASE; HEALTH;
D O I
10.1016/j.chest.2024.01.049
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: Despite effective vaccines against in fl uenza, pneumococcus, and COVID-19, uptake has been suboptimal. RESEARCH QUESTION: Although disparities in vaccination by race and ethnicity have been observed, what is the role of other sociodemographic factors in US vaccine uptake? STUDY DESIGN AND METHODS: We conducted a population-based study using the Rochester Epidemiology Project (REP), a comprehensive medical records linkage system, to assess effects of sociodemographic factors including race, ethnicity, individual-level socioeconomic status (SES) via the housing-based socioeconomic status index, education, population density (urban or nonurban), and marital status with uptake of in fl uenza, pneumococcal, and COVID-19 vaccination in high-risk adults. Adults at high risk of invasive pneumococcal disease residing in four counties in southeastern Minnesota who were aged 19 to 64 years were identi fi ed. Vaccination data were obtained from the Minnesota Immunization Information Connection and REP from January 1, 2010, through December 31, 2021. RESULTS: We identi fi ed 45,755 residents. Most were White (82%), non-Hispanic (94%), married (56%), and living in an urban setting (81%), with three-quarters obtaining at least some college education (74%). Although 45.1% were up to date on pneumococcal vaccines, 60.1% had completed the primary COVID-19 series. For in fl uenza and COVID-19, higher SES, living in an urban setting, older age, and higher education positively correlated with vaccination. Magnitude of differences in race, education, and SES widened with booster vaccines. INTERPRETATION: This high-risk population is undervaccinated against preventable respiratory diseases, especially in fl uenza and pneumococcus. Although national data reported improvement of disparities in COVID-19 vaccination uptake observed early in the pandemic, our data demonstrated gaps related to race, education level, SES, and age that widened with booster vaccines. Communities with high social vulnerabilities often show increased risk of severe disease outcomes, yet demonstrate lower uptake of preventive services. This highlights the need to understand better vaccine compliance and access in rural, lower SES, lesseducated, Black, Hispanic, and younger populations, each of which were associated independently with decreased vaccination. CHEST 2024; 166(1):49-60
引用
收藏
页码:49 / 60
页数:12
相关论文
共 32 条
  • [1] Pneumococcal Vaccine Coverage in Adults Aged 19-64 Years, Newly Diagnosed With Chronic Conditions in the U.S
    Petigara, Tanaz
    Zhang, Dongmu
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2018, 54 (05) : 630 - 636
  • [2] Uptake of 13-Valent Pneumococcal Conjugate Vaccine among US Adults Aged 19 to 64 Years with Immunocompromising Conditions
    Vietri, Jeffrey
    Harnett, James
    Emir, Birol
    Chilson, Erica
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (01) : 161 - 168
  • [3] Influenza, pneumococcal, and COVID-19 vaccination coverage and hesitancy in adults with psychiatric disorders
    Pervane, Vasfiye Demir
    Uyar, Betul
    Bucaktepe, Pakize Gamze Erten
    FRONTIERS IN PSYCHIATRY, 2025, 16
  • [4] Cost-Effectiveness of Influenza Vaccination Strategies in Adults: Older Adults Aged ≥65 Years, Adults Aged 50-64 Years, and At-Risk Adults Aged 19-64 Years
    Choi, Min Joo
    Shin, Gyeongseon
    Kang, Daewon
    Lim, Jae-Ok
    Kim, Yun-Kyung
    Choi, Won Suk
    Yun, Jae-Won
    Noh, Ji Yun
    Song, Joon Young
    Kim, Woo Joo
    Choi, Sang-Eun
    Cheong, Hee Jin
    VACCINES, 2022, 10 (03)
  • [5] RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010-2022
    Haeberer, Mariana
    Mengel, Martin
    Fan, Rong
    Toquero-Asensio, Marina
    Martin-Toribio, Alejandro
    Liu, Qing
    He, Yongzheng
    Uppal, Sonal
    Rojo-Rello, Silvia
    Dominguez-Gil, Marta
    Hernan-Garcia, Cristina
    Fernandez-Espinilla, Virginia
    Liang, Caihua
    Begier, Elizabeth
    Castrodeza Sanz, Javier
    Eiros, Jose M.
    Sanz-Munoz, Ivan
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (09) : 1983 - 1999
  • [6] Pneumococcal vaccination coverage among adults aged 19 to 64 years with immuno-compromising conditions, cerebrospinal fluid (CSF) leaks, or cochlear implants in the US
    Deb, Arijita
    Mohanty, Salini
    Ou, Wanmei
    Rajagopalan, Srinivasan
    Johnson, Kelly D.
    EXPERT REVIEW OF VACCINES, 2021, 20 (03) : 331 - 345
  • [7] Sociodemographic disparities affect COVID-19 vaccine uptake in non-elderly adults with increased risk of severe COVID-19
    Hedberg, Pontus
    Sotoodeh, Adonis
    Askling, Helena H. H.
    Naucler, Pontus
    JOURNAL OF INTERNAL MEDICINE, 2023, 294 (05) : 640 - 652
  • [8] COVID-19 vaccine acceptance among high-risk populations in Uganda
    Bongomin, Felix
    Olum, Ronald
    Andia-Biraro, Irene
    Nakwagala, Frederick Nelson
    Hassan, Khalid Hudow
    Nassozi, Dianah Rhoda
    Kaddumukasa, Mark
    Byakika-Kibwika, Pauline
    Kiguli, Sarah
    Kirenga, Bruce J.
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2021, 8
  • [9] A COVID-19 vaccination program for high-risk children aged 12-17 years in Curacao
    Janssen, Lindy J. F.
    Lo-A-Njoe, Shirley M.
    ten Pas, Charlotte
    Duits, Ashley J.
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2023, 47
  • [10] COVID-19 Vaccine Misperceptions in a Community Sample of Adults Aged 18-49 Years in Australia
    Pickles, Kristen
    Copp, Tessa
    Meyerowitz-Katz, Gideon
    Dodd, Rachael H.
    Bonner, Carissa
    Nickel, Brooke
    Steffens, Maryke S.
    Seale, Holly
    Cvejic, Erin
    Taba, Melody
    Chau, Brian
    McCaffery, Kirsten J.
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (11)